Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 healthy volunteer pharmacokinetics and oral bioavailability study of SAR441566
NL-OMON59810Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of balinatunfib (2 arms), sponsored by Sanofi. Started Mar 2024; status: completed.
02
Drugs
balinatunfib
Beyond the preview
Go deeper on NL-OMON59810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59810.